Pub Date	Title	Publisher	Ref #
Jan 1997	Palmitoylation of the V2 Vasopressin Receptor	Molecular Pharmacology	149 (AR,AB,LT)
Sep 2006	Pathogenesis and Treatment of Autosomal-Dominant Nephrogenic Diabetes Insipidus Caused by an Aquaporin 2 Mutation	Proceedings of the National Academy of Sciences of the U.S.A	710 (AR,AB,LT)
Jul 2003	Pathogenesis of Nephrogenic Diabetes Insipidus by Aquaporin-2 C-Terminus Mutations	Kidney International	613 (AB)
Jan 2003	Pathophysiological Roles of Arginine Vasopressin and Aquaporin-2 in Impaired Water Excretion	Clinical Endocrinology	581 (AR,AB)
Nov 1998	Pathophysiology of Aquaporin-2 in Water Balance Disorders	American Journal of Medicine and Science	202 (AB,LT)
Sep 1998	Pathophysiology of Renal Fluid Retention	Kidney International Supplement	399 (AB)
Jan 1996	Pathophysiology of the Aquaporin Water Channels	Annual Review of Physiology	44 (AB,LT)
Oct 1994	Patients with Autosomal Nephrogenic Diabetes Insipidus Homozygous for Mutations in the Aquaporin 2 Water-Channel Gene	American Journal of Human Genetics	88 (AR,AB,LT)
Jan 2006	Pemetrexed-Induced Acute Renal Failure, Nephrogenic Diabetes Insipidus, and Renal Tubular Acidosis in a Patient with Non-Small Cell Lung Cancer	Medical Oncology	712 (AR,AB,LT)
Feb 1997	Persistent Nephrogenic Diabetes Insipidus Following Lithium Therapy	Scottish Medical Journal	173 (AR,AB,LT)
Aug 2004	Pharmacochaperones Post-Translationally Enhance Cell Surface Expression by Increasing Conformational Stability of Wild-Type and Mutant Vasopressin V2 Receptors	Journal of Biological Chemistry	660 (AR,AB,LT)
Jan 2006	Pharmacologic Chaperones as a Potential Treatment for X-linked Nephrogenic Diabetes Insipidus	Journal of American Society of Nephrology	701 (AR,AB,LT)
Jan 2007	Pharmacological Chaperones in Nephrogenic Diabetes Insipidus: Possibilities for Clinical Application	BioDrugs	724 (AR,AB,LT)
Apr 2000	Pharmacological Chaperones Rescue Cell-Surface Expression and Function of Misfolded V2 Vasopressin Receptor Mutants	Journal of Clinical Investigation	494 (AR,AB,LT)
Dec 2000	Pharmacological Chaperones: A New Twist on Receptor Folding	Trends in Pharmacological Sciences	507 (AB)
Jul 2004	Pharmacological Chaperones: Potential Treatment for Conformational Diseases	Trends in Pharmacological Sciences	655 (AB,LT)
Apr 2007	Phenotypes Developed in Secretin Receptor-Null Mice Indicated a Role for Secretin in Regulating Renal Water Reabsorption	Molecular and Cellular Biology	720 (AR,AB,LT)
Mar 1996	Phosphorylation of Aquaporin-2 does not alter the Membrane Water Permeability of Rat Papillary Water Channel-containing Vesicles	Journal of Biological Chemistry	434 (AR,AB,LT)
Jan 1997	Phosphorylation of the V2 Vasopressin Receptor	The Journal of Biological Chemistry	148 (AR,AB,LT)
Jan 2002	Physiological Importance of Aquaporin Water Channels	Annals of Medicine	564 (AB)
Aug 2000	Physiological relevance of aquaporins: luxury or necessity?	European Journal of Physiology	550 (AB)
Dec 1996	Physiology and Pathophysiology of Aquaporins	European Journal of Clinical Investigation	251 (LT)
Mar 1999	Physiology and Pathophysiology of Renal Aquaporins	Journal of the American Society of Nephrology	597 (AR,AB)
Jan 1998	Physiology and Pathophysiology of the Aquaporin-2 Water Channel	Current Opinion in Nephrology and Hypertension	250 (AB,LT)
Aug 1987	Physiology of ADH Secretion	Kidney International Supplement	471 (AB)
Jul 1995	Plasma Membrane Localization and Functional Rescue of Truncated Forms of a G Protein-coupled Receptor	Journal of Biological Chemistry	249 (AR,AB)
Apr 1991	Platelet Vasopressin Receptors in Patients With Congenital Nephrogenic Diabetes Insipidus	Kidney International	325 (AR,AB,LT)
Aug 1999	Polarized Expression of the Vasopressin V2 Receptor in Madin-Darby Canine Kidney Cells	Kidney International	493 (AR,AB,LT)
Dec 1990	Polyuria and Polydipsia. Problems Associated with Patient Evaluation	Problems in Veterinary Medicine	435 (AB,LT)
Nov 1991	Polyuria in Childhood	Clinical Pediatrics	313 (AB,LT)
Jan 2003	Possible Liposomal Amphotericin B-Induced Nephrogenic Diabetes Insipidus	The Annals of Pharmacotherapy	574 (AB,LT)
Feb 1993	Posterior Lobe of the Pituitary in Diabetes Insipidus: Dynamic MR Imaging	Radiology	141 (AR,AB,LT)
Dec 1982	Potential Role of Increased Sympathetic Activity in Impaired Sodium and Water Excretion in Cirrhosis	New England Journal of Medicine	228 (AB)
Apr 1994	Prevention of Intracranial Calcifications and Brain Damage Associated with Nephrogenic Diabetes Insipidus [Letter; Comment]	Pediatric Nephrology	108 (AB,LT)
Aug 1991	Primary Hyperparathyroidism and Coexisting Nephrogenic Diabetes Insipidus: Rapid Postoperative Correction	Southern Medical Journal	318 (AB,LT)
May 1997	Prolongation of Antidiuretic Response to Desmopressin Acetate by Iontophoretic Transdermal Delivery in Rats	Biological and Pharmaceutical Bulletin	169 (AR,AB,LT)
Jul 1997	Properties of a New Radioiodinated Antagonist for Human Vasopressin V2 and V1a Receptors	European Journal of Pharmacology	362 (AB)
Jan 1996	Properties of the Human Arginine Vasopressin V2 Receptor after Site-Directed Mutagenesis of its Putative Palmitoylation Site	Biochemical Journal	236 (AR,AB,LT)
Apr 1995	Proposed Cause of Marked Vasopressin Resistance in a Female with an X-Linked Recessive V2 Receptor Abnormality	Journal of Clinical Endocrinology and Metabolism	71 (AR,AB,LT)
Oct 2003	Proteomic Analysis of Long-Term Vasopressin Action in Inner Medullary Collecting Duct of Brattleboro Rat	American Journal of Physiology: Renal Physiology	631 (AR,AB)
Nov 1992	Purification and Partial Characterization of Candidate Antidiuretic Hormone Water Channel Proteins of Mr 55,000 and 53,000 from Toad Urinary Bladder	Journal of Biological Chemistry	273 (AR,AB)